Clinical Trial Update: DEXTENZA Therapy for Treatment of Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 trial update for DEXTENZA therapy in allergic conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Bilateral Conjunctivitis

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: Clinical Research Center of Florida | Conditions: Bilateral Conjunctivitis (Disorder) | Phase 4 | Status: COMPLETED